Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01232231 |
Date of registration:
|
01/11/2010 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting
|
Scientific title:
|
Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus in the Outpatient Setting: a Randomized Controlled Study |
Date of first enrolment:
|
July 2010 |
Target sample size:
|
15 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT01232231 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Canada
| | | | | | | |
Contacts
|
Name:
|
Thomas J Louie, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Calgary |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Prior MRSA infection (i.e index case)
- Identified as being colonized with MRSA on initial screen
Exclusion Criteria:
- Are pregnant or breastfeeding.
- Have indwelling catheters.
- Received prior decolonization treatment within last 6 months of enrollment.
- Have allergy to study medication.
- Are colonized with MRSA strain resistant to study medication.
- Have active infection requiring systemic antimicrobials.
- Are household contacts to index case.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Methicillin-resistant Staphylococcus Aureus
|
Intervention(s)
|
Drug: pharmacological decolonization treatment
|
Behavioral: Education
|
Primary Outcome(s)
|
Eradication of MRSA carriage
[Time Frame: 90 days after randomization]
|
Secondary Outcome(s)
|
Occurrence of MRSA infection
[Time Frame: Within 6 months of randomization]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|